Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2024 is 225.00% vs 33.33% in Sep 2023
Consolidate Net Profit
YoY Growth in quarter ended Sep 2024 is 26.13% vs 13.95% in Sep 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2024 is 36.67% vs 14.98% in Sep 2023
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2024 has improved from Sep 2023
Compare Quarterly Results Of Omega Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2024 is 23.81% vs -12.50% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 225.00% vs 33.33% in Sep 2023
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2024 is -0.61% vs 18.91% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 26.13% vs 13.95% in Sep 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2024 is 16.88% vs 13.98% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 36.67% vs 14.98% in Sep 2023
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2024 has improved from Jun 2024
YoY Growth in quarter ended Sep 2024 has improved from Sep 2023






